Research ExplorerPublicationsCancer therapy monitoring in xenografts by quantitative anal...

Cancer therapy monitoring in xenografts by quantitative analysis of circulating tumor DNA.

Standard

Cancer therapy monitoring in xenografts by quantitative analysis of circulating tumor DNA. / Gorges, Tobias; Schiller, Johanna; Schmitz, Arndt; Schuetzmann, Daniel; Schatz, Christoph; Zollner, Thomas M; Krahn, Thomas; von Ahsen, Oliver.

In: BIOMARKERS, Vol. 17, No. 6, 6, 2012, p. 498-506.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Gorges, T, Schiller, J, Schmitz, A, Schuetzmann, D, Schatz, C, Zollner, TM, Krahn, T & von Ahsen, O 2012, 'Cancer therapy monitoring in xenografts by quantitative analysis of circulating tumor DNA.', BIOMARKERS, vol. 17, no. 6, 6, pp. 498-506. <http://www.ncbi.nlm.nih.gov/pubmed/22616911?dopt=Citation>

APA

Gorges, T., Schiller, J., Schmitz, A., Schuetzmann, D., Schatz, C., Zollner, T. M., Krahn, T., & von Ahsen, O. (2012). Cancer therapy monitoring in xenografts by quantitative analysis of circulating tumor DNA. BIOMARKERS, 17(6), 498-506. [6]. http://www.ncbi.nlm.nih.gov/pubmed/22616911?dopt=Citation

Vancouver

Gorges T, Schiller J, Schmitz A, Schuetzmann D, Schatz C, Zollner TM et al. Cancer therapy monitoring in xenografts by quantitative analysis of circulating tumor DNA. BIOMARKERS. 2012;17(6):498-506. 6.

Bibtex

@article{f55687b83ecb4cc8b2ade47b7c21cb8e,
title = "Cancer therapy monitoring in xenografts by quantitative analysis of circulating tumor DNA.",
abstract = "Circulating tumor DNA (ctDNA) is a promising biomarker in cancer.",
keywords = "Animals, Humans, Male, Female, Reference Standards, Mice, Kinetics, Cell Line, Tumor, Case-Control Studies, DNA/*blood, Tumor Markers, Biological/*blood, Mice, Nude, Xenograft Model Antitumor Assays/*methods, Antineoplastic Agents/administration & dosage, Tumor Burden, Breast Neoplasms/*blood/drug therapy/pathology, Colorectal Neoplasms/*blood/drug therapy/pathology, Diphenylamine/administration & dosage/analogs & derivatives, Real-Time Polymerase Chain Reaction/standards, Sulfonamides/administration & dosage, Animals, Humans, Male, Female, Reference Standards, Mice, Kinetics, Cell Line, Tumor, Case-Control Studies, DNA/*blood, Tumor Markers, Biological/*blood, Mice, Nude, Xenograft Model Antitumor Assays/*methods, Antineoplastic Agents/administration & dosage, Tumor Burden, Breast Neoplasms/*blood/drug therapy/pathology, Colorectal Neoplasms/*blood/drug therapy/pathology, Diphenylamine/administration & dosage/analogs & derivatives, Real-Time Polymerase Chain Reaction/standards, Sulfonamides/administration & dosage",
author = "Tobias Gorges and Johanna Schiller and Arndt Schmitz and Daniel Schuetzmann and Christoph Schatz and Zollner, {Thomas M} and Thomas Krahn and {von Ahsen}, Oliver",
year = "2012",
language = "English",
volume = "17",
pages = "498--506",
journal = "BIOMARKERS",
issn = "1354-750X",
publisher = "informa healthcare",
number = "6",

}

RIS

TY - JOUR

T1 - Cancer therapy monitoring in xenografts by quantitative analysis of circulating tumor DNA.

AU - Gorges, Tobias

AU - Schiller, Johanna

AU - Schmitz, Arndt

AU - Schuetzmann, Daniel

AU - Schatz, Christoph

AU - Zollner, Thomas M

AU - Krahn, Thomas

AU - von Ahsen, Oliver

PY - 2012

Y1 - 2012

N2 - Circulating tumor DNA (ctDNA) is a promising biomarker in cancer.

AB - Circulating tumor DNA (ctDNA) is a promising biomarker in cancer.

KW - Animals

KW - Humans

KW - Male

KW - Female

KW - Reference Standards

KW - Mice

KW - Kinetics

KW - Cell Line, Tumor

KW - Case-Control Studies

KW - DNA/blood

KW - Tumor Markers, Biological/blood

KW - Mice, Nude

KW - Xenograft Model Antitumor Assays/methods

KW - Antineoplastic Agents/administration & dosage

KW - Tumor Burden

KW - Breast Neoplasms/blood/drug therapy/pathology

KW - Colorectal Neoplasms/blood/drug therapy/pathology

KW - Diphenylamine/administration & dosage/analogs & derivatives

KW - Real-Time Polymerase Chain Reaction/standards

KW - Sulfonamides/administration & dosage

KW - Animals

KW - Humans

KW - Male

KW - Female

KW - Reference Standards

KW - Mice

KW - Kinetics

KW - Cell Line, Tumor

KW - Case-Control Studies

KW - DNA/blood

KW - Tumor Markers, Biological/blood

KW - Mice, Nude

KW - Xenograft Model Antitumor Assays/methods

KW - Antineoplastic Agents/administration & dosage

KW - Tumor Burden

KW - Breast Neoplasms/blood/drug therapy/pathology

KW - Colorectal Neoplasms/blood/drug therapy/pathology

KW - Diphenylamine/administration & dosage/analogs & derivatives

KW - Real-Time Polymerase Chain Reaction/standards

KW - Sulfonamides/administration & dosage

M3 - SCORING: Journal article

VL - 17

SP - 498

EP - 506

JO - BIOMARKERS

JF - BIOMARKERS

SN - 1354-750X

IS - 6

M1 - 6

ER -